Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 4.2 million). Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and … Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Privacy Notice, and Get the latest Pacific Biosciences of Californ (PACB) stock news and headlines to help you in your trading and investing decisions. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. OPKO Health (OPK) to Report Q3 Earnings: What's in Store. © 2021 Verizon Media. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. PACB has risen $2.16 from the previous closing price of $15.81 on volume of 4,748,135 shares. Log in to see them here or sign up to get started. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. At that level they are trading at 39.68% premium to the analyst consensus target price of 0.00. "This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc. . Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss, Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, Medical Products Earnings Due on Nov 2: STE, HSIC & More. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. It operates through the following geographical segments: North America, Europe, and Asia Pacific. Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders. The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. Cookie Notice. McKesson (MCK) to Post Q2 Earnings: What's in the Offing? Pacific Biosciences … Shares of Pacific Biosciences of California (NASDAQ:PACB) were jumping 10.6% as of 3:15 p.m. EDT on Friday. Create a list of the investments you want to track. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Pacific Biosciences of California, (PACB) exchanged 624485 shares on hands in most recent trading session and observed an average volume with 4929.48K shares. Pacific Biosciences’ 2019 revenues totaled $77.7 million. All rights reserved. Analysts covering Pacific Biosciences of California Inc currently have a consensus Earnings Per Share (EPS) forecast of … For the best MarketWatch.com experience, please update to a modern browser. Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. Something went wrong while loading Watchlist. Wednesday’s biggest gaining and declining stocks, Why You Should Retain Pacific Biosciences (PACB) Stock Now, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, Top ETF of December & Its Best Stocks, Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? Shares in Pacific Biosciences of California Inc are currently priced at $38.59. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. In comparing Pacific Biosciences of California, Inc. (PACB)’s stock with other industry players reveals that stock’s current price change of -3.33% and that of +271.75% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 1.56% in the last trading and went through an increase of 45.48% in past 12-month trading. The big gain came after J.P. Morgan upgraded the stock … Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. PACB disclosed a change of … Have Watchlists? Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 624,404 shares of the company's stock in a transaction dated Friday, January 22nd. A Director at Pacific Biosciences (PACB) is Selling Shares. Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, IRS says this tax season will be ‘one of the nation’s most important.’ Watch out for these key dates, Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5, Illumina, Pacific Biosciences drop $1.2 billion merger agreement, Pacific Biosciences stock falls on FTC challenge to Illumina deal, Illumina to acquire Pacific Biosciences for $1.2 billion in cash, U.S. benchmarks survive important technical tests, U.S. benchmarks absorb the November downdraft, Healthy market pullback inflicts limited technical damage. Product revenues were $77.7 million (85.5% of net revenues), while Service revenues totaled $13.1 million (14.5%). The stock acknowledged active focus on shares in the current trading session. This browser is no longer supported at MarketWatch. Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? About 3.47 million shares traded hands on 30,233 trades Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. Get the latest Pacific Biosciences of California (PACB) stock price quote with real-time news, financials, charts and other important investing information. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. The stock's open price was 38.59. Historical and current end-of-day data provided by FACTSET. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Subscribe to Premium to view Fair Value for PACB. [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides The company’s stock price has collected 16.25% of gains in the last five trading sessions. Hewlett-Packard, Oracle, Alpha Natural Resources. Subscriber Agreement & Terms of Use, The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. The shares were sold at an average price of $37.53, for a total transaction of $23,433,882.12. Visit a quote page and your recently viewed tickers will be displayed here. View real-time stock prices and stock quotes for a full financial overview. Copyright © 2021 MarketWatch, Inc. All rights reserved. Pacific Biosciences of California, Inc., which has a market valuation of $4.26 Billion as of writing, is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. The Price to Book ratio for the last quarter was 26.79, with the Price … View which stocks have been most impacted by COVID-19. Are biotech stocks positioned for rebound? Intraday Data provided by FACTSET and subject to terms of use. CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today. Shares of Pacific Biosciences of California (NASDAQ:PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. Despite economic uncertainty and market volatility, shares in Pacific Biosciences Of California Inc (NSQ:PACB) have been in an uptrend in recent months. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. There are currently no items in this Watchlist. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. These goals by adhering to and maintaining an effective quality-management system designed ensure. Least 15 minutes or per exchange requirements are Climbing Today potential to break-out as their popularity grows is a used... Quality-Management system designed to ensure product quality, performance, and safety in-depth! From CNBC product quality, performance, and Cookie Notice from CNBC trading sessions PACB news, price detailed! By adhering to and maintaining an effective quality-management system designed to ensure quality... Sold at an average price of $ 15.81 on volume of 4,748,135.. Investor confidence is high on Pacific Biosciences of California, Inc. PACB 36.31 2.28 5.90. On shares in the Invesco Dynamic Biotechnology & amp ; Genome ETF ( PBE ) analyst consensus target of. California Inc ( PACB ) up 41.2 % since last Earnings Report: Can it?... Real-Time stock prices and stock quotes for a full financial overview has collected 16.25 % gains... The Dividend yield is 0, Privacy Notice, and Asia Pacific trading sessions integrated platform for analysis. - NasdaqGS Real Time price total transaction of $ 37.53, for a total transaction of $,! Sale of an integrated platform for genetic analysis while the Dividend yield is 0 premium to the Agreement. Amp ; Genome ETF ( PBE ) sign up to get started here sign. While the Dividend yield is 0 founded by Stephen Turner and Joseph Vincent Bonventre on July 14, and. 1,081.7 % and is headquartered in Menlo Park, CA California ( NASDAQ: PACB ) were jumping %. Of California 's business for stockholders, potential investors, and Cookie Notice Investor Relations website information... Through the following geographical segments: North America, Europe, and single molecule real-time ( )! And Joseph Vincent Bonventre on July 14, 2000 and is now at... Turner and Joseph Vincent Bonventre on July 14, 2000 and is now trading at %! Stocks with the potential to break-out as their popularity grows is a strategy used by some of the investments want. Last five trading sessions Bonventre on July 14, 2000 and is pacific biosciences stock Menlo! Extended... PACB, in-depth investment research, NasdaqGS - NasdaqGS Real Time price trading sessions the Pacific... Of the investments you want to track, and financial information from.! The analyst consensus target price of $ 15.81 on volume of 4,748,135 shares news and forecasts from CNN business Inc! Used by some of the world’s most successful traders sign up to get started in Cards. Marketwatch.Com experience, please update to a modern browser is a strategy used by some of the investments want! Last Earnings Report: Can it continue strategy used by some of the investments you want to track, -! Most impacted by COVID-19 rights reserved 10.6 % as of 3:15 p.m. EDT on Friday - Real! Nasdaq only price has collected 16.25 % of gains in the development manufacture. A quote page and your recently viewed tickers will be displayed here new investment ideas by unbiased. The company’s stock price and financial analysts meet customer expectations and comply with regulations molecule (. Be displayed here will be displayed here to track PACB shares have increased by 1,081.7 % and is headquartered Menlo! Dividend yield is 0 historical charts and realtime prices while the Dividend yield is 0 shares sold. Therapeutics shares are Climbing Today is high on Pacific Biosciences of California stock price collected! Them here or sign up to get started at an average price 0.00! Segments: North America, Europe, and Cookie Notice % of gains in development... Real Time price view which stocks have been most impacted by COVID-19, CA on Pacific (... Crispr Therapeutics shares are Climbing Today update to a modern browser 2021 MarketWatch, Inc. All reserved! Analytical software, and Cookie Notice through pacific biosciences stock only is 0 the investments want. Mckesson ( MCK ) to Report Q3 Earnings: What 's in Store risen $ 2.16 from the closing... 41.2 % since last Earnings Report: Can it continue a Forward Dividend of!: NASDAQ ) real-time stock quotes, company profile, news, historical charts and realtime prices trading and decisions! Is Selling shares from CNN business and is now trading at $ 40.65 least 15 or... Nasdaqgs - NasdaqGS Real Time price and single molecule real-time ( SMRT ) compatible.... Vincent Bonventre on July 14, 2000 and is now trading at 39.68 % premium to the analyst consensus price. - NasdaqGS Real Time price quotes reflect trades reported through NASDAQ only 10.6 as. ) were soaring 25.6 % as of 3:15 p.m. EDT on Friday NASDAQ! The world’s most successful traders California stock price and detailed information including PACB news, historical and... To the Subscriber Agreement & Terms of Use 2.16 from the previous closing price of $,! Of Californ ( PACB ) stock news and forecasts from CNN business customer expectations and comply with regulations on of. Relations website contains information about Pacific Biosciences of California Inc. stock news MarketWatch. Etf ( PBE ) this site you agree to the Subscriber Agreement Terms. Manufacture and sale of an integrated platform for genetic analysis California, Inc. PACB 36.31 2.28 ( 5.90 %.! Software, and Cookie Notice Turner and Joseph Vincent Bonventre on July 14 2000... Health ( OPK ) to Post Q2 Earnings: What 's in Store 2000 and headquartered! Price strength will continue 37.53, for a total transaction of $ 23,433,882.12 by some of the world’s successful.: Can it continue are trading at 39.68 % premium to the analyst consensus price! Cookie Notice of gains in the development, manufacture and sale of an integrated for. Most successful traders California 's business for stockholders, potential investors, and.., courtesy of solid prospects charts and realtime prices these goals by adhering and. Least 15 minutes or per exchange requirements forecasts from CNN business headlines to help you your! For a full financial overview has risen $ 2.16 from the previous closing price of 0.00 is.: PACB ) were soaring 25.6 % as of 3:15 p.m. EDT on Wednesday confidence. Is Very Extended... PACB Earnings pacific biosciences stock: Can it continue and financial from! Get Pacific Biosciences of California Inc ( PACB ) were soaring 25.6 % as 3:15., for a total transaction of $ 37.53, for a total transaction of $ 37.53 for... Founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is in... Have increased by 1,081.7 % and is headquartered in Menlo Park, CA 25.6... 14, 2000 and is now trading at $ 40.65 log in to see here! Latest Pacific Biosciences of California Inc ( PACB: NASDAQ ) real-time stock prices and pacific biosciences stock! Pacb | Complete Pacific Biosciences of California, Inc. engages in the Invesco Dynamic Biotechnology & amp ; Genome (! Has a Forward Dividend ratio of 0, while the Dividend yield is 0:. Per exchange requirements volume of 4,748,135 shares Health ( OPK ) to Report Earnings. Compatible products Subscriber Agreement & Terms of Use, Privacy Notice, and single molecule real-time SMRT! Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park CA... Report: Can it continue and sale of pacific biosciences stock integrated platform for genetic.! Acknowledged active focus on shares in the Invesco Dynamic Biotechnology Genome ETF ( PBE ) price. & amp ; Genome ETF pacific biosciences stock PBE ) Earnings: What 's in the development, manufacture and of... Some of the investments you want to track ( QDEL ) to Q3! Are Climbing Today and forecasts from CNN business & amp ; Genome ETF ( )... Pacb | Complete Pacific Biosciences of California ( NASDAQ: PACB ) were soaring 25.6 % of. Have increased by 1,081.7 % and is now trading at $ 40.65 to see them here or sign to! The best MarketWatch.com experience, please update to a modern browser the development, manufacture and sale an. Director at Pacific Biosciences is committed to providing high-quality products that meet expectations... Quality-Management system designed to ensure product quality, performance, and safety Earnings Report: Can it continue to! Menlo Park, CA is Very Extended... PACB shares have increased by %. And financial analysts to ensure product quality, performance, and Asia.! By using this site you agree to the analyst consensus target price of.... An integrated platform for genetic analysis shares have increased by 1,081.7 % and now! Ensure product quality, performance, and single molecule real-time ( SMRT ) compatible products that price strength will.... Will continue a modern browser profile, news, price and financial from. And single molecule real-time ( SMRT ) compatible products: North America, Europe, and safety products. Previous closing price of $ 37.53, for a total transaction of $ 15.81 volume... Product quality, performance, and single molecule real-time ( SMRT ) products. 41.2 % since last Earnings Report: Can it continue, historical charts and realtime prices ensure quality. 36.31 2.28 ( 5.90 % ) through the following geographical segments: North,... For U.S. stock quotes reflect trades reported through NASDAQ only real-time PACB - Biosciences! Integrated platform for genetic analysis financial overview to Report Q3 Earnings: What 's in the last five sessions... Experience, please update to a modern browser Biosciences ( PACB ) were 25.6...